当将某种物质视为潜在的内分泌干扰物时，ECHA 会参考哪些外部清单？许多声称具有内分泌干扰效应的出版物，其使用的检测方法未经验证或数据质量低劣。

当将某种物质视为潜在的内分泌干扰物时，ECHA 会参考哪些外部清单？许多声称具有内分泌干扰效应的出版物，其使用的检测方法未经验证或数据质量低劣。

When considering a substance as a potential endocrine disruptor, which external lists does ECHA consult? There are a number of publications claiming endocrine disruptor effects that use unvalidated assays or poor quality data.

对于IT筛查，我们使用外部疑似ED清单，例如委员会、WHO、TEDX和SIN清单。MSCA在手动筛查过程中会根据具体情况评估现有证据的可靠性。然而，物质被列入“ED清单”绝不会作为怀疑其潜在ED的独立标准，而是始终与其他信息结合使用。不同的信息来源及其使用方式在每年更新的定义文件中进行了描述：http://echa.europa.eu/screening。

For the IT-screening, we use external lists of suspected ED such as the Commission, WHO, TEDX and SIN lists. Further evaluation steps during the manual-screening conducted by the MSCAs will assess the reliability of the available evidence on a case by case basis. However, the listing of a substance in an “ED-list” is never used as stand-alone criterion to suspect a substance as potential ED but always in combination with other information. The different sources of information and how these are used are described in the definition document that is updated annually at: http://echa.europa.eu/screening.